Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSV-2 DNA vaccine trial in adults with genital herpes
ACTRN12615000094572Phase 2Completed
- Sponsor
- Admedus Vaccines
- Start
- Mar 2015
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of HSV-2 DNA vaccine in genital herpes (4 arms), sponsored by Admedus Vaccines. Primary endpoint: Safety. Started Mar 2015; status: completed.
02
Drugs
HSV-2 DNA vaccine
03
Conditions
genital herpes
Beyond the preview
Go deeper on ACTRN12615000094572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000094572.